Pfizer Stories | Articles & Content Features

Go To Section

Articles
Behind the Science Features
Podcasts
eBooks
Subscriptions

Articles

Decoding the Complex Science of Obesity

GLP-1. GIP. Amylin. Incretins. Peptides. NuSH.It’s not hard to see why the language surrounding modern obesity research sometimes feels like an alphabet soup of scientific terms. But behind each is a growing understanding of how the body regulates hunger, metabolism, energy use, and weight. It’s shaping what we know about how those systems might contribute to obesity.Recent research suggests that more than 1 billion people worldwide are now living with obesity, and that number is estimated to....

May Social Media Round-Up—ASCO, Q1 2026 Results, and More

Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla....

Turning Silence Into Advocacy: Women Reshaping Cancer Conversations

The sixth season of Science Will Win, Pfizer’s award-winning podcast, focused on cancer, with each episode tackling a different aspect of the fight against the disease. Host Dr. Raven Baxter delved deep into a variety of topics within oncology, interviewing doctors, scientists, researchers, and Pfizer colleagues to glean their insights and discuss their efforts to eventually conquer cancer.To further the conversation, each of the five podcast episodes was accompanied by a full-length video....

For this Pfizer Scientist, Cancer Research is Personal

For Shuo Wang, cancer research isn’t just a job - it’s personal.Wang, a scientist in Pfizer’s oncology research unit, remembers when one of her close friends was diagnosed with stage four lung cancer shortly after giving birth to her second child. The experience happened early in her career, and deepened Wang’s determination to make a meaningful impact.Wang and her team spend their days planning experiments, analyzing data, and working together to help advance cancer treatments. Along with....

Lung Cancer: Real Risks, Common Myths, and Why Screening Matters

Can you name the top three cancer diagnoses affecting Americans? Did you guess breast (#1), prostate (#2), or colon (#4)? Those are good picks, but there’s another type of cancer that takes the number three spot: lung.1Lung cancer is the third-most diagnosed type of cancer in the country.2 Smoking remains the No. 1 risk factor for developing lung cancer,3 but 10 to 20 percent of lung cancers occur in people who have never smoked before (or who have smoked fewer than 100 cigarettes in their whole....

Building an AI-Fluent Organization: How Pfizer is helping colleagues understand, embrace, and apply AI

Pfizer has been utilizing artificial intelligence (AI) across our business for some time, but recent advancements in technology combined with advancements in biology are converging to create a scientific renaissance set to transform health as we know it. That reality is already upon us.According to Pfizer CEO Albert Bourla, the biggest barrier to unlock this potential is fear of the unknown. "It is not a question of technology," Bourla said in a recent conversation with Nikolai Tangen of the....

Research Rising: Recognizing Clinical Trials Day 2026

Before a breakthrough reaches a patient, it moves through years of research, which is shaped by questions, tested through data, and strengthened by collaboration.At Pfizer, that work is always in motion. Across diseases, geographies, and phases of clinical trial development, our teams are advancing research with urgency. Clinical trials are a critical part of that effort. They connect science with real-world impact, helping us understand how potential medicines and vaccines perform and how they....

Pfizer’s New San Diego R&D Hub Accelerates the Next Wave of Cancer Innovation

A state-of-the-art campus designed to turn scientific ambition into breakthroughs for people with cancerFor more than two decades, Pfizer has pushed the boundaries of cancer care, developing medicines that have helped transform treatment for some of the world’s most challenging cancers. That progress continues to fuel an ambition to keep expanding what’s possible – an ambition brought to life in San Diego, where a new state-of-the-art campus has been purpose-built to help advance science and....

Podcast Highlights Pfizer Foundation’s Mission to Improve Breast Cancer Outcomes

For over 75 years, the Pfizer Foundation, a charitable organization, has worked toward the mission of helping build healthier communities around the world. By investing in locally led organizations and applying a community-centered approach, the Foundation aims to address today’s complex global health challenges, respond to urgent health needs, and empower Pfizer colleagues to make a positive impact where they live, work, and beyond.Launched in 2025, The Pfizer Foundation’s Action & Impact....

Behind the Science Features

What are ADCs? Targeting cancer with special drug delivery units

For centuries, humanity has hoped for a world where people with cancer live better, longer lives – and today that vision is closer than ever. Learn how antibody drug conjugates (ADCs) are emerging as one of the most powerful tools in cancer treatment.

Ever Wonder How Drugs Get Their Names?

Naming medications is not a simple process. It's a collaborative, conscientious effort, and one that is both an art and a science. Take a peek behind the curtain to see how drugs are named.

Understanding Obesity as a Complex Disease

Some people think obesity is simply caused by unhealthy eating habits and not exercising enough. But, in fact, the scientific and medical community defines obesity as a complex, multifactoral chronic disease.

See more Behind the Science Features